The University of Chicago Header Logo

Connection

Robert Naclerio to Rhinitis

Back to Details
This is a "connection" page, showing publications Robert Naclerio has written about Rhinitis.
Robert Naclerio
Connection Strength
10.063
Rhinitis
  1. Unblocking the Treatment Stalemate in Chronic Rhinosinusitis Without Nasal Polyposis (CRSsNP). J Allergy Clin Immunol Pract. 2024 04; 12(4):1062-1064.
    View in: PubMed
    Score: 0.723
  2. A Decade of Clinical Advances in Chronic Rhinosinusitis: 2012-2022. J Allergy Clin Immunol Pract. 2023 01; 11(1):43-50.
    View in: PubMed
    Score: 0.663
  3. Management of the Upper Airway Distress During Pregnancy. Immunol Allergy Clin North Am. 2023 02; 43(1):53-64.
    View in: PubMed
    Score: 0.655
  4. The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 Era. J Allergy Clin Immunol Pract. 2020 09; 8(8):2492-2494.
    View in: PubMed
    Score: 0.557
  5. Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop. J Allergy Clin Immunol Pract. 2020 05; 8(5):1532-1549.e1.
    View in: PubMed
    Score: 0.545
  6. A Pragmatic Approach Towards Sinonasal Diseases. J Allergy Clin Immunol Pract. 2020 05; 8(5):1556-1558.
    View in: PubMed
    Score: 0.544
  7. Persistence of Sinonasal Disease Despite Mepolizumab. J Allergy Clin Immunol Pract. 2020 05; 8(5):1550-1555.
    View in: PubMed
    Score: 0.542
  8. Other Phenotypes and Treatment of Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2016 Jul-Aug; 4(4):613-20.
    View in: PubMed
    Score: 0.423
  9. Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review. Int Forum Allergy Rhinol. 2015 Jul; 5(7):590-6.
    View in: PubMed
    Score: 0.389
  10. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
    View in: PubMed
    Score: 0.282
  11. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol. 2008 Aug; 122(2):415-7.
    View in: PubMed
    Score: 0.243
  12. Effect of topical ciprofloxacin/dexamethasone or dexamethasone alone on acute Streptococcus pneumoniae rhinosinusitis in mice. Otolaryngol Head Neck Surg. 2008 Mar; 138(3):340-6.
    View in: PubMed
    Score: 0.237
  13. Cold air-induced rhinitis. Clin Allergy Immunol. 2007; 19:267-81.
    View in: PubMed
    Score: 0.219
  14. Environmental and allergic factors in chronic rhinosinusitis. Clin Allergy Immunol. 2007; 20:25-49.
    View in: PubMed
    Score: 0.219
  15. Allergic rhinitis augments the response to a bacterial sinus infection in mice: A review of an animal model. Am J Rhinol. 2006 Sep-Oct; 20(5):524-33.
    View in: PubMed
    Score: 0.214
  16. Persistent inflammation and hyperresponsiveness following viral rhinosinusitis. Laryngoscope. 2006 Jul; 116(7):1236-40.
    View in: PubMed
    Score: 0.211
  17. The effect of treatment with moxifloxacin or azithromycin on acute bacterial rhinosinusitis in mice. Int J Infect Dis. 2006 Sep; 10(5):401-6.
    View in: PubMed
    Score: 0.207
  18. Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
    View in: PubMed
    Score: 0.204
  19. Acute bacterial rhinosinusitis causes hyperresponsiveness to histamine challenge in mice. Arch Otolaryngol Head Neck Surg. 2005 Oct; 131(10):905-10.
    View in: PubMed
    Score: 0.201
  20. Evaluation of LYR-220 Mometasone Sinonasal Implants in Patients With Chronic Rhinosinusitis and Prior Ethmoid Surgery: Results From the Randomized, Blinded, Controlled BEACON Phase 2 Study. Int Forum Allergy Rhinol. 2025 Aug; 15(8):818-827.
    View in: PubMed
    Score: 0.193
  21. Chronic Rhinosinusitis of Odontogenic Origin. J Allergy Clin Immunol Pract. 2021 Jul; 9(7):2894-2895.
    View in: PubMed
    Score: 0.149
  22. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 03; 11(3):213-739.
    View in: PubMed
    Score: 0.146
  23. Bactrim reduces the inflammatory response in a murine model of acute rhinosinusitis. Rhinology. 2000 Jun; 38(2):68-71.
    View in: PubMed
    Score: 0.139
  24. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 01; 58(1):10-17.
    View in: PubMed
    Score: 0.136
  25. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
    View in: PubMed
    Score: 0.133
  26. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.128
  27. A mouse model of acute bacterial rhinosinusitis. Arch Otolaryngol Head Neck Surg. 1998 Nov; 124(11):1227-32.
    View in: PubMed
    Score: 0.124
  28. Rhinitis and inhalant allergens. JAMA. 1997 Dec 10; 278(22):1842-8.
    View in: PubMed
    Score: 0.117
  29. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016 Feb; 6 Suppl 1:S22-209.
    View in: PubMed
    Score: 0.103
  30. Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
    View in: PubMed
    Score: 0.099
  31. Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Aug; 4(8):609-16.
    View in: PubMed
    Score: 0.091
  32. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013 Jun; 131(6):1479-90.
    View in: PubMed
    Score: 0.085
  33. Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis. Am J Rhinol Allergy. 2012 Sep-Oct; 26(5):371-9.
    View in: PubMed
    Score: 0.081
  34. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.081
  35. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.073
  36. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
    View in: PubMed
    Score: 0.069
  37. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009 Nov; 121(6):121-39.
    View in: PubMed
    Score: 0.067
  38. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope. 2008 Nov; 118(11):2067-72.
    View in: PubMed
    Score: 0.062
  39. The osmolality of nasal secretions increases when inflammatory mediators are released in response to inhalation of cold, dry air. Am Rev Respir Dis. 1988 Mar; 137(3):625-9.
    View in: PubMed
    Score: 0.059
  40. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
    View in: PubMed
    Score: 0.059
  41. Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007 Nov-Dec; 10(6):457-65.
    View in: PubMed
    Score: 0.058
  42. Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006 Nov; 135(5 Suppl):S31-80.
    View in: PubMed
    Score: 0.054
  43. Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol. 2006 Nov; 118(5 Suppl):S17-61.
    View in: PubMed
    Score: 0.054
  44. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.052
  45. Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004 Dec; 131(6 Suppl):S1-62.
    View in: PubMed
    Score: 0.047
  46. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol. 2004 Dec; 114(6 Suppl):155-212.
    View in: PubMed
    Score: 0.047
  47. Antiallergic effects of H1-receptor antagonists. Allergy. 2000; 55 Suppl 64:17-27.
    View in: PubMed
    Score: 0.034
  48. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.029
  49. Monoclonal Antibodies for the Treatment of Nasal Polyps. Immunol Allergy Clin North Am. 2017 05; 37(2):357-367.
    View in: PubMed
    Score: 0.028
  50. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.025
  51. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
    View in: PubMed
    Score: 0.020
  52. Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol. 2012; 158(3):216-31.
    View in: PubMed
    Score: 0.019
  53. Histamine stimulation of the nasal mucosa does not induce prostaglandin or leukotriene generation or induce methacholine hyperresponsiveness. Int Arch Allergy Appl Immunol. 1991; 95(2-3):149-55.
    View in: PubMed
    Score: 0.018
  54. The effects of H1 antihistamines on the early allergic response. Ann Allergy. 1989 Dec; 63(6 Pt 2):551-5.
    View in: PubMed
    Score: 0.017
  55. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
    View in: PubMed
    Score: 0.015
  56. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
    View in: PubMed
    Score: 0.015
  57. Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
    View in: PubMed
    Score: 0.013
  58. Mediator release during nasal provocation. A model to investigate the pathophysiology of rhinitis. Am J Med. 1985 Dec 20; 79(6A):26-33.
    View in: PubMed
    Score: 0.013
  59. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.013
  60. Sinusitis: bench to bedside. Current findings, future directions. J Allergy Clin Immunol. 1997 Jun; 99(6 Pt 3):S829-48.
    View in: PubMed
    Score: 0.007
  61. Sinusitis: bench to bedside. Current findings, future directions. Otolaryngol Head Neck Surg. 1997 Jun; 116(6 Pt 2):S1-20.
    View in: PubMed
    Score: 0.007
  62. The role of kinins in human allergic disease. N Engl Reg Allergy Proc. 1986 May-Jun; 7(3):213-8.
    View in: PubMed
    Score: 0.003
  63. The pharmacologic control of mediator release from human basophils and mast cells. Respiration. 1986; 50 Suppl 2:116-22.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.